RenovoRx, Inc. Common Stock (RNXT) is a publicly traded Healthcare sector company. As of July 29, 2026, RNXT trades at $0.92 with a market cap of $43.53M and a P/E ratio of -2.69. RNXT moved +0.00% today. Year to date, RNXT is +8.00%; over the trailing twelve months it is -27.42%. Its 52-week range spans $0.70 to $1.69. Analyst consensus is strong buy with an average price target of $7.00. Rallies surfaces RNXT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
4 analysts cover RNXT: 0 strong buy, 4 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $7.00.
| Metric | Value |
|---|---|
| Price | $0.92 |
| Market Cap | $43.53M |
| P/E Ratio | -2.69 |
| EPS | $-0.33 |
| Dividend Yield | 0.00% |
| 52-Week High | $1.69 |
| 52-Week Low | $0.70 |
| Volume | 1.68K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.58M |
| Net Income | $-12.27M |
| Gross Margin | 74.04% |
4 analysts cover RNXT: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $7.00.